The abstract submitted to the Scientific Program Committee should have a maximum of 350 words.
Submission and responsibilities of the corresponding author
To submit your abstract, please use http://abstracts.hodgkinsymposium.org/ to register and have access to the template and the submission process.
The first author listed for each abstract serves as the corresponding author for all correspondence regarding the abstract, unless otherwise specified. The corresponding author is responsible for the following:
Approval of all co-authors on the content of the abstract and agreement to be co-authors.
Informing all co-authors on any changes of the abstract.
Notifying all co-authors of the publication of accepted abstracts in a supplement of the Journal HemaSphere
Notification regarding acceptance of abstracts will be sent to the corresponding author via e-mail in August 2018. Abstracts of superior quality will be selected by the Scientific Program Committee for presentation at the ISHL11.
Once an abstract is submitted, a written request must be submitted no later than September 10, 2018, to email@example.com if the corresponding author chooses to withdraw the abstract for any reason. Abstracts will not be withdrawn after this deadline.
Responsibilities of the Presenting Author
The presenting author must be one of the co-authors listed on the submitted abstract but does not need to be the corresponding author. It is the responsibility of the presenting author to obtain all of the conflict-of-interest disclosures from co-authors.